Jun 12, 2024, 08:00
Erman Akkus on a paper by Ruben Malmberg, et al.
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Oral antihistamine cetirizine instead of iv clemastine in paclitaxel pre-medication.
- Oral cetirizine is safe,
- Hypersensitivity reactions grade ≥3 incidence: 1.6% (n = 3) in the clemastine and 0.5% (n = 1) in the cetirizine,
- Difference: -1.2% (90% CI, –3.4 to 1.1).”
Read further
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25
Nov 13, 2024, 14:55
Nov 13, 2024, 14:47
Nov 13, 2024, 14:43
Nov 13, 2024, 14:37
Nov 13, 2024, 14:05